Colorectal cancer screening service
Related entities
Findings (27)
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals
None
adverseOne-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (
Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals